Inovio Pharmaceuticals
INO
INO
98 hedge funds and large institutions have $49.5M invested in Inovio Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 27 increasing their positions, 20 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
1.9% more ownership
Funds ownership: 31.1% → 33% (+1.9%)
24% less capital invested
Capital invested by funds: $65.1M → $49.5M (-$15.6M)
Holders
98
Holding in Top 10
–
Calls
$1.71M
Puts
$1.27M
Top Buyers
| 1 | +$1.25M | |
| 2 | +$1.04M | |
| 3 | +$836K | |
| 4 |
GC
GMT Capital
Atlanta,
Georgia
|
+$729K |
| 5 |
DM
Deerfield Management
New York
|
+$442K |
Top Sellers
| 1 | -$1.52M | |
| 2 | -$460K | |
| 3 | -$391K | |
| 4 |
AGM
Alpine Global Management
New York
|
-$201K |
| 5 |
CIC
Cornercap Investment Counsel
Atlanta,
Georgia
|
-$184K |